A detailed history of Scout Investments, Inc. transactions in Axonics, Inc. stock. As of the latest transaction made, Scout Investments, Inc. holds 62,507 shares of AXNX stock, worth $4.22 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
62,507
Previous 94,127 33.59%
Holding current value
$4.22 Million
Previous $5.86 Million 26.4%
% of portfolio
0.11%
Previous 0.16%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$56.67 - $69.36 $1.79 Million - $2.19 Million
-31,620 Reduced 33.59%
62,507 $4.31 Million
Q4 2023

Feb 13, 2024

BUY
$49.38 - $63.75 $4.65 Million - $6 Million
94,127 New
94,127 $5.86 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.32B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Scout Investments, Inc. Portfolio

Follow Scout Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scout Investments, Inc. with notifications on news.